Skip to main content

Find Clinical Trials

Home
Conditions
Bronchial Neoplasms

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

[177Lu]Lu-AKIR001 First-in-human Study

NCT06639191

Conditions: Bronchial Neoplasms, Cancer Head and Neck, Carcinoma, +31 more
Locations: Karolinska University hospital Stockholm, Stockholm County, Sweden

View Trial Details

Recruiting

IMPT Dose Escalation for NSCLC (HyDose)

NCT06484491

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: UMCG Groningen, Netherlands

View Trial Details

Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

NCT05983432

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +62 more
Locations: Beverly Hills Cancer Center Beverly Hills, California, United States

City of Hope Cancer Center Duarte, California, United States

Chao Family Comprehensive Cancer Care and Ambulatory Care Irvine, California, United States

Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

View all 39 locations

View Trial Details

Recruiting

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

NCT07148128

Conditions: Advanced Solid Tumors, Advanced or Metastatic KRAS-mutant Tumor, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, +28 more
Locations: NEXT Oncology Dallas Dallas, Texas, United States

Next Oncology, San Antonio San Antonio, Texas, United States

Princess Margareth Cancer Center Toronto, Ontario, Canada

Oxford University Hospital Headington, Oxford, United Kingdom

View Trial Details

Recruiting

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

NCT07376707

Conditions: Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

NCT07374614

Conditions: ALK, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

NCT07371663

Conditions: Ataxia, Ataxia Telangiectasia, Brain Diseases, +60 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, Henan, China

Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

NCT07373964

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: The First Affiliated Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Recruiting

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

NCT04467723

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: The University of Kansas Cancer Center (KUCC) Fairway, Kansas, United States

The University of Kansas Cancer Center, Westwood Campus Kansas City, Kansas, United States

View Trial Details

Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

NCT05150691

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +45 more
Locations: Helios Clinical Research Cerritos, California, United States

California Research Institute Los Angeles, California, United States

Sharp Memorial Hospital San Diego, California, United States

Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C., District of Columbia, United States

View all 102 locations

View Trial Details